Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Cipla
Farmers Insurance
Teva
Daiichi Sankyo
AstraZeneca
Accenture
Baxter
Citi

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,472,563

« Back to Dashboard

Which drugs does patent 6,472,563 protect, and when does it expire?

Patent 6,472,563 protects BROVANA and is included in one NDA.

This patent has thirteen patent family members in twelve countries.
Summary for Patent: 6,472,563
Title: Formoterol tartrate process and polymorph
Abstract:A method of preparation of a highly pure salt of R,R-formoterol L-tartrate is disclosed. The process provides the most thermodynamically stable polymorph by recrystallization of a novel polymorph.
Inventor(s): Tanoury; Gerald J. (Hudson, MA), Senanayake; Chris H. (Shrewsbury, MA), Kessler; Donald W (Groton, MA)
Assignee: Sepracor Inc. (Marlborough, MA)
Application Number:10/037,183
Patent Claim Types:
see list of patent claims
Compound; Process; Use; Composition; Delivery; Dosage form;

Drugs Protected by US Patent 6,472,563

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Sunovion BROVANA arformoterol tartrate SOLUTION;INHALATION 021912-001 Oct 6, 2006 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 6,472,563

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,110,706 Formoterol tartrate process and polymorph ➤ Try a Free Trial
7,342,132 Formoterol tartrate process and polymorph ➤ Try a Free Trial
6,720,453 Formoterol tartrate polymorph ➤ Try a Free Trial
7,964,753 Formoterol tartrate process and polymorph ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 6,472,563

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 450497 ➤ Try a Free Trial
Australia 2002349914 ➤ Try a Free Trial
Australia 2008253696 ➤ Try a Free Trial
Canada 2477642 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Fish and Richardson
Julphar
US Army
Federal Trade Commission
Cantor Fitzgerald
McKesson
Citi
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.